[18F]FET PET for Characterization of Progressive or Recurrent Glioma From Treatment Related Changes

Clinical trial NCT07238322 · COMPLETED

Trial details

NCT number: NCT07238322
Sponsor: Telix Pharmaceuticals (Innovations) Pty Limited
Status: COMPLETED
Study type: OBSERVATIONAL

Retrospective Study Glioma Brain Neoplasms

Start date: 2025-09-22
Primary completion: 2026-01-23
Enrollment: 253

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.